Issa, Naiem
Alexis, Andrew
Baldwin, Hilary
Hamzavi, Iltefat
Hebert, Adelaide
Kwong, Pearl
Lain, Edward
Moore, Angela
Noor, Omar
Schlesinger, Todd
Weiss, Jonathan
Woolery-Lloyd, Heather
York, JP
Holcomb, Kate Zibilich
Kircik, Leon
Chavda, Rajeev https://orcid.org/0000-0002-1959-1563
Article History
Received: 11 October 2024
Accepted: 16 January 2025
First Online: 21 February 2025
Declarations
:
: Dr. Naiem Issa has acted as a speaker, consultant and/or advisor for AbbVie, Almirall, Bristol-Myers Squibb, Castle Biosciences, Dermavant Sciences, DermTech, Galderma, Incyte, Journey, LEO Pharma, Lilly, National Eczema Association, Ortho Dermatologics, Pfizer, Regeneron, Sanofi, SUN Pharma, UCB, Verrica Pharmaceuticals and WebMD. Prof. Andrew Alexis has received grants (funds to institution) from LEO Pharma, Amgen, Galderma, Arcutis, Dermavant, AbbVie and Castle; participated on advisory boards or as a consultant for LEO Pharma, Galderma, Pfizer, Sanofi-Regeneron, Dermavant, Beiersdorf, Ortho, L’Oréal, Bristol-Myers Squibb, Bausch Health, UCB Pharma, Arcutis, Janssen Pharmaceuticals, Allergan, Almirall, AbbVie, Amgen, VisualDx, Eli Lilly, Swiss American, Cutera, Cara Therapeutics, EPI Health, Incyte Corporation, Castle, Apogee, Alphyn, Canfield, Avita Medical and Genentech; acted as a speaker for Regeneron, Sanofi, Bristol-Myers Squibb, L’Oréal, Janssen Pharmaceuticals and Johnson & Johnson; received royalties from Springer, Wiley-Blackwell and Wolters Kluwer Health; received equipment from Aerolase. Dr. Hilary Baldwin has acted as an investigator, consultant and/or speaker for Almirall, Bausch Health, Cassiopeia, EPI Health, Galderma, La Roche-Posay, L’Oréal, Mayne Pharma, Sol–Gel, Sun Pharma and Vyne. Dr. Iltefat Hamzavi has acted as a consultant and investigator AbbVie, Pfizer, Incyte, UCB, Boehringer Ingelheim, Sonoma, Union therapeutics, Novartis, Jansen, ITN, Avita, Galderma, Vimela, Almirall, Sonoma, Boehringer Ingelheim and Merck. Dr. Adelaide Hebert has received research grants paid to UTHealth McGovern Medical School from Galderma, Ortho Dermatologics, Pfizer, Arcutis, Dermavant, Amgen, Lilly, Leo Pharma; honoraria for consultation/speaker/advisor: Pfizer, Arcutis, Dermavant, Leo Pharma, Incyte, Almirall, Lilly, Beiersdorf and LaRoche-Posay. Dr. Pearl Kwong has acted as investigator, or consultant or speaker for Almirall, Bausch Health/Ortho, Galderma, Cerave, Apogee, AbbVie, Arcutis, Dermavant, Incyte, Sanofi/Regeneron, Pfizer, Eli Lilly, EPI Health UCB, Amgen, Bristol-Myers Squibb, Leo, Sun Pharma, Verrica Pharmaceuticals, Novan, Journey Pharmaceuticals and Novartis. Dr. Edward Lain has served as an investigator, speaker, advisor and/or consultant for AbbVie, Almirall, Amgen, Arcutis, Bausch, Beiersdorf, Bristol-Myers Squibb, Cassiopeia, Cellceutix, Dermavant, Eli Lilly, Galderma, GSK, Incyte, Kenvue, LEO, L’Oreal, Novartis, Pfizer, Pierre Fabre, Regeneron, Sanofi, Sun Pharma, Takeda, UCB Pharma and Vyne. Dr. Angela Moore has received honoraria or research funds from Almirall, Galderma, Mayne, Ortho Dermatologics, Parexel and Vyne. Dr. Omar Noor is a speaker, consultant and/or advisor for AbbVie, Almirall, Amgen Inc, Arcutis, Bristol-Myers Squibb, Castle Biosciences, Dermavant Sciences, DermTech, Galderma, Incyte Corporation, Journey Medical, LEO Pharma, Lilly, Novartis Pharmaceuticals Corporation, Ortho Dermatologics, Pfizer, Procter & Gamble Ventures, Regeneron Pharmaceuticals Inc, Sanofi Genzyme, Sun Pharmaceutical Industries Ltd and UCB. Dr. Todd Schlesinger serves as a consultant, investigator, speaker and/or advisor for AbbVie, Almirall, Allergan (An AbbVie company), ASLAN Pharma, Arcutis, Biofrontera, Beiersdorf, Benev, Bristol-Myers Squibb, Castle Biosciences, Galderma, Eli Lilly, ExoCoBio, Incyte, Janssen, LEO, L’Oreal, Novartis, Pfizer, Regeneron, Sanofi, Sun Pharma, Takeda, UCB Pharma and Verrica Pharmaceuticals. Dr. Jonathan Weiss serves as an advisory board member for Bristol-Myers Squibb, Dermavant Sciences, Foamix, Galderma Laboratories, L.P., Incyte Corporation, Novartis and UCB receiving honoraria; as a consultant for Arcutis, Inc., Biofrontera, Cutera, Inc., Leo Pharma Inc, Ortho Dermatologics and UCB receiving fees or honoraria; as an investigator for AbbVie, Bausch Health, Biofrontera, Bristol-Myers Squibb, Cutera, Inc., Dermavant Sciences, Foamix, Galderma, L.P., LEO Pharma, Mindera, Moberg Pharma North, America LLC, Novartis, Palvella Therapeutics and Verrica Pharmaceuticals Inc receiving grants and research funding; as a speaker for AbbVie, Arcutis, Inc., Galderma, L.P., Ortho Dermatologics, Regeneron and Sanofi Genzyme receiving honoraria. Dr. Heather Woolery-Lloyd has served as a research/investigator for AbbVie, Allergan, Eirion Therapeutics, Galderma, Pfizer and Arcutis. An advisor/consultant for Ortho Dermatologics, AbbVie, Incyte, Johnson & Johnson Consumer, Inc., L’Oréal, Arcutis, Beiersdorf, Unilever, Procter & Gamble, SC Johnson, Kenvue and Galderma. Acted on the speakers' bureau for Incyte, L’Oréal, Ortho Dermatologics, Pfizer and Galderma. Dr. JP York is an employee of Galderma. Dr. Katherine (Kate) Zibilich Holcomb has served as an investigator, speaker, advisor and/or consultant for AbbVie, Almirall, Bristol Myers Squibb, Galderma, Incyte and Sun Pharma. Prof. Leon Kircik has received research grants from AbbVie, Allergan, Almirall, Amgen, Arcutis, Boehringer Ingelheim, Breckenridge Pharma, Bristol-Myers Squibb, Celgene, Cellceutix, Centocor, Combinatrix, Connetics, Coria, Dermavant, Dermira, Dow Pharma, Dr Reddy’s Laboratories, Eli Lilly, Galderma, Genentech, GlaxoSmithKline, Idera, Johnson & Johnson, LEO Pharma, Maruho, Merck, Medicis, Novartis AG, Pfizer, PharmaDerm, Promius, Stiefel, Sun Pharma, UCB Pharma, Valeant and XenoPort; has received honoraria from AbbVie, Allergan, Almirall, Amgen, Arcutis, Biogen Idec, Bristol-Myers Squibb, Celgene, Cipher, Connetics, Dermavant, Dermira, Dr Reddy’s Laboratories, Eli Lilly, Galderma, Genentech, GlaxoSmithKline, Johnson & Johnson, LEO Pharma, Merck, Novartis AG, PharmaDerm, Promius, Serono (Merck Serono International SA), Stiefel, Sun Pharma, Taro, UCB Pharma and Valeant. Dr. Rajeev Chavda is an employee of Galderma.
: Information presented in this article is based on previously conducted studies and does not contain any data from new studies with human participants or animals performed by any of the authors.